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ABSTRACT
Background Low energy availability (EA) in female
athletes with or without an eating disorder (ED)
increases the risk of oligomenorrhoea/functional
hypothalamic amenorrhoea and impaired bone health,
a syndrome called the female athlete triad (Triad). There
are validated psychometric instruments developed to
detect disordered eating behaviour (DE), but no
validated screening tool to detect persistent low EA and
Triad conditions, with or without DE/ED, is available.
Aim The aim of this observational study was to develop
and test a screening tool designed to identify female
athletes at risk for the Triad.
Methods Female athletes (n=84) with 18–39 years of
age and training ≥5 times/week ﬁlled out the Low
Energy Availability in Females Questionnaire (LEAF-Q),
which comprised questions regarding injuries and
gastrointestinal and reproductive function. Reliability and
internal consistency were evaluated in a subsample of
female dancers and endurance athletes (n=37).
Discriminant as well as concurrent validity was evaluated
by testing self-reported data against measured current
EA, menstrual function and bone health in endurance
athletes from sports such as long distance running and
triathlon (n=45).
Results The 25-item LEAF-Q produced an acceptable
sensitivity (78%) and speciﬁcity (90%) in order to
correctly classify current EA and/or reproductive function
and/or bone health.
Conclusions The LEAF-Q is brief and easy to
administer, and relevant as a complement to existing
validated DE screening instruments, when screening
female athletes at risk for the Triad, in order to enable
early detection and intervention.
INTRODUCTION
When energy intake is restricted or inadequate, the
amount of energy available for basic physiological
functions, such as reproductive function, becomes
insufﬁcient.1 2 Therefore, persistent low energy
availability (EA), with or without an eating disorder
(ED) present, may pose a signiﬁcant health risk to
female athletes. There are validated screening tools
for the detection of disordered eating behaviour
(DE) in athletes including the Athletic Milieu Direct
Questionnaire (AMDQ),3 the Female Athlete
Screening Tool (FAST)4 and the American
Physiological Screening Test for eating disorders
among Female College Athletes (PST).5 The preva-
lence of low EA is assumed to be high in female
athletes,1 but there are no screening tools based on
self-reported physiological symptoms of low EA. It
is, therefore, relevant to develop an instrument that
can be routinely and widely used for screening
female athletes to identify individuals at risk of the
female athlete triad (Triad).
EA <125 kJ/kg fat-free mass (FFM) over more
than 5 days has been shown to reduce blood glucose
and leptin levels, to suppress the pulsatility of
gonadotropin-releasing hormone and hypothalamic-
pituitary axis hormones, like luteal hormone (LH)
and triiodothyronine (T3), and to elevate cortisol as
well as to increase bone resorption markers in eume-
norrheic sedentary women.6 7 If maintained for a
longer period, low EA can cause functional hypo-
thalamic amenorrhoea (FHA),2 8 and FHA has been
shown to have a high predictive value when screen-
ing for ED among female athletes.9 Low levels of
oestrogen increase the risk for stress fractures and
osteoporosis,1 10 and results from a study on young
female athletes indicate that restricted eating behav-
iour and FHA may also increase the risk for muscu-
lar and joint overload.11 Orthostatic hypotension is
common among patients with ED,5 10 and the sen-
sation of dizziness when rising from a supine to a
standing position could, therefore, be a symptom of
low EA. Reduced T3 and T4 have been reported in
athletes with FHA12 13 and in patients with ED.14
Hypothyroidism can result in an increased cold sen-
sitivity and could, therefore, be a symptom of low
EA. Persistent low EA could have immunosuppres-
sive consequences, and therefore increase the risk
for infections in athletes.15 Irregular meal patterns
and high ﬁbre intake are commonly reported among
female athletes dieting or with DE1 and can cause a
variety of different gastrointestinal symptoms such
as bloating and constipation.5 16
The aim of this study was to develop a screening
tool, the Low Energy Availability in Females
Questionnaire (LEAF-Q) designed to identify
female athletes at risk for the Triad and evaluate
reliability, internal consistency and discriminants as
well as concurrent validity.
METHOD
A total of 84 female athletes from Sweden and
Denmark, recruited through the national federa-
tions of endurance sport, competitive endurance
sport clubs and professional dancers were included
in the validation of the LEAF-Q. Participants
included were women between 18–39 years of age,
who trained ≥5 times/week. Dancing and endur-
ance sports such as long-distance running and tri-
athlon were chosen as representatives for
leanness-demanding sports, with an increased risk
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for the Triad.17 18 The study had two parts. In part one, the reli-
ability of the LEAF-Q was assessed using endurance athletes and
dancers (n=37). In part two, the self-reported symptoms,
reported on the LEAF-Q, were veriﬁed in another group of
endurance athletes (n=45) using clinical assessments. The exclu-
sion criteria were pregnancy, chronic illness, use of forms of
contraceptives other than oral, for example, hormonal coil, not
being willing to stop with oral contraceptives (OC) for at least
6 weeks prior to investigation or injuries preventing the athlete
from training ≥2 weeks. A total of 47 participants participated
in the clinical veriﬁcation of self-reported symptoms; two
dropped out and 45 were included in the analysis. Permission to
undertake the study was provided by relevant regional ethics
committees in Sweden and Denmark (no 2011/576 and
H-4-2011-096). Physiological symptoms in the literature fre-
quently associated with long-term low EA and/or other Triad
conditions were included as variables in the LEAF-Q after being
veriﬁed as especially relevant by a collective clinical expertise in
endocrinology, sports nutrition, medicine and gastroenterology.
Internal consistency and reliability
The ﬁrst version of the LEAF-Q included 29 items distributed
on ﬁve main variables (injuries, dizziness, cold sensitivity, gastro-
intestinal function and menstrual dysfunction (MD), including
questions regarding the use of OC). Since these endurance ath-
letes and dancers (n=37) were of English, Swedish and Danish
origin, the LEAF-Q was, from the start, translated by two bilin-
gual employees at the University of Copenhagen. A test–retest
was performed to assess item performance and estimate reliabil-
ity. The participants received the LEAF-Q twice within a 2-week
period and a letter of information to which the participants
were asked to reply within 2 days. After ﬁlling out the LEAF-Q
the second time, the participants were interviewed to assess
response bias. The participants were asked to comment whether
questions or response categories were not clearly stated,
whether they perceived any question as irrelevant, whether
response options were inadequate and whether the volume of
the questionnaire was appropriate. One variable, illness, was
added.
Veriﬁcation of self-reported symptoms
The version of the LEAF-Q used in the next part of the valid-
ation process included 14 items in the introduction, including
occupation, type of sport, age, height, weight and training, fol-
lowed by 30 items divided into six variables: dizziness, gastro-
intestinal function, cold sensitivity, illnesses (during the last
year), injuries (during the previous year) and menstrual function
(present and in the past). The variables for dizziness and cold
sensitivity included one item assessed by self-reporting the fre-
quency of the symptom on a Likert-type ordinal scale: (1) Yes,
several times a day; (2) Yes, several times a week; (3) Yes, 1–2
times a week and (4) Rarely or never. The injury and illness
variable contained three items for which the frequency and dur-
ation were assessed by ordinal scales and an open category to
specify the types of injuries/illness. The open response for the
variable of injuries was divided into two main types of injuries
—accidental or overload. The variable for gastrointestinal func-
tion contained four items and was assessed by self-reporting
gastrointestinal symptoms such as pain/cramps/bloating on a
Likert-type ordinal scale. Nominal scales assessed stool fre-
quency and consistency. Menstrual function included 12 items
and was measured on dichotomous as well as ordinal scales. Age
of menarche was measured on an ordinal scale and previous
MD on a nominal scale. Bleeding pattern related to exercise was
measured on dichotomous and nominal scales. The use of hor-
monal contraceptives contained six items and was assessed on
dichotomous and nominal scales. After ﬁlling out the LEAF-Q,
the endurance athletes (n=47) were invited to take part in a
standardised veriﬁcation programme to verify self-reported
symptoms by assessment of EA, clinical veriﬁcation of DE/ED,
orthostatic BP, hypothyroidism, reproductive function and bone
health.
Dietary intake and training intensity were recorded by the
participants for seven consecutive days to assess EA.19 The parti-
cipants were instructed to maintain and follow their normal
eating pattern and training regime. Energy intake was calculated
from weighed food records using a nutrient analysis pro-
gramme, Dankost 2000 (Dankost, Copenhagen, Denmark), for
Danish foods and Dietist XP (Kost och Näringsdata AB,
Bromma, Sweden) for Swedish food items.
The participants were instructed to maintain and follow their
normal training regime. Heart rate (HR) monitors (Polar
RS400, Stockholm, Sweden) were used to assess exercise energy
expenditure (EEE) based on individual prediction equations
from measured HR and corresponding energy expenditure (EE)
during an incremental maximal exercise test in the laboratory.
The individual equation provided the basis for the calculation of
EEE using HR measurement for each training session.20
Regression lines were calculated for the corresponding values of
HR and EE during the incremental exercise test in the labora-
tory. HR were highly correlated with O2 consumption during
increasing workloads (r=0.94, 95% CI 0.93 to 0.96). EA was
calculated by subtracting mean EEE from the mean energy
intake, after calculating EEE by subtracting from total EEE the
total EE during an equivalent time period without exercise. To
calculate daily total EE, HR monitors (Polar RS400) were used
to assess EE during bicycle transportation; actigraphy
(ActiGraph GT3X, Pensacola, Florida, USA) and the data ana-
lysis software ActiLife 5 (ActiGraph) were used for the assess-
ment of non-exercise physical activity thermogenesis. The
participants were instructed to wear an accelerometer on the
wrist during sleep, and on the hip from the time they wake up
in the morning until bedtime, taking it off only during shower-
ing, swimming, bicycle transportation and training.
Eating behaviour was assessed using the Eating Disorder
Inventory (EDI-3), a questionnaire assessing behaviour and atti-
tudes related to DE behaviour.21 Participants were categorised
as having DE behaviour when the subscale drive for thinness
was ≥14 and/or body dissatisfaction ≥19.21 The Eating
Disorder Examination (EDE-16.0)22 was used to determine
whether participants met the criteria for ED according to the
Diagnostic and Statistical Manual of Mental Disorders, Fourth
Edition (DSM-IV) criteria for anorexia nervosa, bulimia nervosa
and ED not otherwise speciﬁed. All interviews were performed
by the same EDE-certiﬁed member of the research team.
Participants using OC were requested to stop for a minimum
of six weeks prior to examination in order to secure a sufﬁcient
washout period for exogenous oestrogen and progesterone.
Participants not recovering their menstrual bleeding within the
six weeks were monthly contacted by the research team during
a follow-up period of minimum of three months before gynae-
cological assessment. Menstruating athletes were examined in
the early follicular phase, deﬁned as the third to ﬁfth day of
menstruation. A pregnancy test was performed and menstrual
function was examined by an experienced gynaecologist who
performed a transvaginal ultrasound examination. The
maximum number of ovarian follicles present in a single plane
was counted and the total volume of these follicles was assessed.
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Sex hormone status (oestrogen, LH, follicle stimulating
hormone (FSH) and androgens) and anamnestic assessment,
including age of menarche, OC and previous MD were
recorded. Participants were then classiﬁed as eumenorrhoea
(menstrual cycles of 28 days±7 days); oligomenorrhoea (men-
strual cycles >35 days); FHA (either primary; no menarche after
15 years of age, or secondary; absence of ≥3 consecutive men-
strual cycles); other MD (anatomic defects, hyperprolactinemia
or other dysfunctional ovarian conditions); polycystic ovary syn-
drome (PCOS; ≥2 of the following criteria fulﬁlled: (1) enlarged
ovaries with a volume greater than 10 mL and/or ≥one ovary
demonstrating ≥12 follicles in one plane, (2) oligomenorrhoea/
amenorrhoea and (3) elevated androgen level or otherwise
androgen stigmatised).
Body weight was measured, with the participants in under-
wear, on an electronic scale and height was measured using a
ﬁxed stadiometer. Dual-energy X-ray absorptiometry (DEXA;
Hologic, Model Discovery 2009, Hologic Inc Waltham,
Massachusetts, USA) was used to determine fat-free, fat and bone
mass. All measurements and scans were performed in the fasted
state between 7:30 and 9:00, and were assessed by the same tech-
nician and performed on the same scanner. Calibration of the
DEXA was performed weekly using a phantom provided by the
manufacturer. The participants were classiﬁed as having normal
bone mineral density (BMD) when Z-scores were >−1 in all
measured sites, low BMD when Z-score was −1 to −2 in at least
one site and osteoporosis when Z-score was ≤−2.1
Changes in blood pressure (BP) when moving from a supine
to a standing position were measured using a standardised tilt
table and an electronic sphygmomanometer (Microlife BP A100,
Widnau, Switzerland). After resting in a supine position for
7 min, BP was measured three times before (the mean was used)
and once directly after tilting the participants to 70° standing
position. Hypotension was deﬁned as a supine systolic BP
<90 mm Hg and/or a diastolic BP <60 mm Hg. Orthostatic
hypotension was deﬁned as a fall in systolic BP >20 mm Hg
and/or a fall in diastolic BP >10 mm Hg when moving from a
supine to a standing position.5 23
Blood samples were drawn from an antecubital vein in a
resting state after an overnight fast. Oestrogen, FSH, LH and
androgen were analysed using ADVIA Centaur Immunoassay
Systems (Siemens Healthcare Diagnostics Products GmbH,
Germany). The analytical sensitivity was 18.4–15 781 pmol/L
for oestrogen, 0.3–200 IU/L for FSH, 0.07–200 IU/L for LH
and 0.1–28.0 nmol/L for androgen. The intra-assay and interas-
say precision coefﬁcient of variability (CV) for oestrogen was
2.6% and 4.1%, for FSH 1.2% and 2.0% and for LH 2.9% and
2.3%. The CV for androgen was 4.7% at 7.5 nmol/L. T3 was
analysed using the ARCHITECT system assay (Abbott
Laboratories, Longford, Ireland) with an analytical sensitivity of
≤0.25–8 ng/mL and a total assay precision CV of <10%.
Capillary blood glucose was analysed using Biosen C Line (EKF
Diagnostic, Germany) with a measurement range between 0.5
and 50 mmol/L and a CV of 1.5% at 12 mmol/L. Cortisol was
analysed using Roche Electro Chemiluminiscence Immunoassay
(ECLI, Roche Diagnostic, Bromma, Sweden). Analytical sensitiv-
ity for the cortisol assay was 0.5–1750 nmol/L with an assay
precision CV of 1.3–2.1%. Leptin was analysed using
Quantikine ELISA (R&D Systems Europe Ltd, Abingdon, UK).
The lower analytical limit for leptin was 1.56 ng/mL; lower con-
centrations are associated with some uncertainty, and therefore
not automatically calculated. Seven participants had results
<1.56 ng/mL, and in order to calculate their concentrations, the
concentration was extrapolated using the formula for the
standard curve: log10 (ABS)=A× Log10 (concentration) –
B→concentration= 10log10 (ABS)+B))/A. The intra-assay and inter-
assay precision CV for leptin was 3.0–3.3% and 3.5–5.4%,
respectively.
Statistical methods
Distributional features of variables were measured on a continu-
ous scale (height, etc) and variable scores were examined for
central tendency. Skewed data were log transformed before
further analysis. The intraclass correlation coefﬁcient was used
to calculate the difference between the test and test–retest
scores. In this group of female endurance athletes, oligomenor-
rhoea/FHA existed with and without the presence of low
current EA (<125 kJ/kg FFM/day). Owing to this mismatch, the
participants were divided into 50% with the highest current EA
and 50% with the lowest current EA, to examine discriminant
validity. The statistical procedure for questionnaire validation
described by Black et al5 was used, where discriminant validity
was assessed by testing the mean item score for each of the six
variables for signiﬁcant difference (two-sample t tests) between
the groups with lower EA versus higher EA, MD versus eume-
norrhoea and low BMD versus normal BMD. To measure con-
current validity and the degree of association among the total
LEAF-Q score, LEAF-Q variables and Triad conditions,
Pearson’s correlation coefﬁcient (r) was calculated. Furthermore,
the contribution of LEAF-Q variables to the different Triad con-
ditions was calculated using an ordinal logistic regression.
Pearson’s correlation coefﬁcient (r) was also calculated to assess
the degree of association between self-reported training hours
per week and training hours registered during the week of data
collection, as well as self-reported and measured body weight.
For comparison of means between the participants categorised
at risk for the Triad versus those categorised with low risk,
Student’s paired t test was used. To test whether there was a dif-
ference between the two kinds of classiﬁcations, for example,
the number of participants categorised at risk for the Triad
versus those categorised with low risk having MD, Fisher’s
exact test was applied. Statistical signiﬁcance was declared for
p<0.05. Internal consistency between questionnaire variables
was examined by Cronbach’s α.24 The items found to signiﬁ-
cantly predict lower EA, MD and/or low BMD were retained
and summed up to provide an overall LEAF-Q score. To test the
validity of the LEAF scale, sensitivity and speciﬁcity were
calculated.
RESULTS
During the ﬁrst part of development and testing reliability
(n=37), internal consistency testing of the main variables
resulted in an overall α of 0.86, suggesting a relatively high
homogeneity of the LEAF-Q. The intraclass correlation coefﬁ-
cient was used to calculate the difference between the test and
the test–retest score. Test–retest reliability was 0.79 after a
two-week interval of retesting. The responders found all the
questions relevant, easy to read and understand. The response
options were, in general, adequate but an open response cat-
egory to individual explanations was lacking in items regarding
training, injuries, menstruation and OC, and this was, therefore,
addressed in the ﬁnal version used for validation.
EA was 120±46 kJ/kg FFM/day in the group with the lower
current EA and 205±29 kJ/kg FFM/day in the group with the
higher current EA. Twenty-four participants were diagnosed
with FHA/oligomenorrhoea, three with PCOS and two with
other MD. Twenty-one had low BMD (Z-score ≤−1). Eleven
participants were diagnosed with an ED, and, in addition, one
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was classiﬁed as having DE. Seven participants had hypotension
in a supine position, while one participant had orthostatic hypo-
tension. One participant had hypothyroidism (T3<1.2 ng/mL),
32 had low leptin levels (<3.88 pg/mL), 16 had hypoglycaemia
(<4 mmol/L) in the fasted and rested state and one had elevated
cortisol (>800 nmol/L).
Self-reported training hours/week correlated with registered
training hours/week (r=0.49, p<0.01) and self-reported body
weight to measured body weight (r=0.97, p<0.001). The vari-
able scores for gastrointestinal symptoms, injuries and MD
showed signiﬁcant differences between the groups—gastrointes-
tinal symptom: lower current EA versus higher current EA
(p=0.023); injury: low BMD versus high BMD (p=0.021) and
menstrual function: MD vs eumenorrhoea (p<0.001). These
three variables were signiﬁcantly associated with a lower current
EA and/or MD and/or low BMD using a logistic regression
(table 1), and the mean variable score for the remaining vari-
ables correlated with the total LEAF-Q score (table 2). The
three variables had values of Cronbach’s α ≥0.71 (table 3); they
were, therefore, retained and provided an overall LEAF-Q score.
The variable score producing the highest sensitivity and speci-
ﬁcity for the corresponding Triad end point was used as the
cut-off for each item score (≥2 for gastrointestinal symptoms,
≥2 for injuries and ≥4 for MD). The total LEAF-Q score ≥8.0
produced a sensitivity of 78% and a speciﬁcity of 90% for cor-
rectly classifying current EA and/or reproductive function and/
or bone health. When excluding the athletes with PCOS and
other MD than oligomenorrhoea/FHA, the total LEAF-Q score
produced a sensitivity of 83% and a speciﬁcity of 90%, with an
overall validity of 73% for correctly classifying current EA and/
or reproductive function and/or bone health (see online supple-
mental digital content 1; The LEAF-Q and 2; The LEAF-Q
scoring key).
Summary statistics for all participants (n=45) participating in
the veriﬁcation programme and divided as participants cate-
gorised at risk for the Triad (total LEAF-Q score ≥8) versus
those categorised as having low risk (total LEAF-Q score <8)
are shown in table 4. Participants at risk for the Triad had a
lower body fat and there was a trend towards lower body
weight and BMI compared with participants categorised with
low risk. Furthermore, the participants at high risk had lower
levels of leptin, T3 as well as fasting blood glucose compared
with participants with low risk, while there was no difference in
cortisol levels.
More participants categorised as at risk for the Triad were
diagnosed with MD and hypoglycaemia, while there were no
signiﬁcant differences in the number of participants diagnosed
with DE/ED, impaired bone health or hypotension between the
groups (table 5).
DISCUSSION
The intension of the LEAF-Q was to construct a brief question-
naire focusing only on self-reported physiological symptoms
linked to persistent energy deﬁciency, with or without DE/ED,
which can be routinely used to identify individuals at risk of the
Triad. Overall, the LEAF-Q had an acceptable sensitivity and
speciﬁcity as well as internal consistency, indicating that it has
the potential to be a useful screening tool for the identiﬁcation
of female athletes at risk for the Triad and a relevant comple-
ment to existing validated DE screening instruments.
In contrast to pure psychometric scales, on which direct meas-
uring of the underlying concept is impossible, the validity
testing of the LEAF-Q included the veriﬁcation of self-reported
symptoms linked to the three endpoints of the Triad by objective
conﬁrmation. This created an opportunity to test the score of
the LEAF-Q against measured current EA, MD and bone health,
and to calculate the sensitivity and speciﬁcity of the
LEAF-Q. The sensitivity and speciﬁcity found indicate that the
LEAF-Q has the ability not only to correctly characterise eight
of ten female athletes with lower current EA and/or oligomenor-
rhoea/FHA and/or low BMD, but also to correctly classify nine
of 10 athletes with higher current EA, eumenorrhoea and
normal BMD.
DE behaviour and ED are most often accompanied by energy
deﬁciency and other end points of the Triad.25–27 The preva-
lence of DE/ED in this study was high (n=12, 27%). Only 58%
of these participants had, however, lower current EA, while they
all had additional MD and/or low BMD. The LEAF-Q was not
constructed to discriminate between normal and pathological
eating behaviour, but to detect female athletes at risk for the
Triad. Findings of either one of the end points in the Triad when
using the LEAF-Q should, therefore, implicate assessment for
the other conditions, including a pathological eating behaviour.
Gastrointestinal problems are commonly reported in female
endurance athletes28 and in patients with DE/ED.1 5 In this
group of female endurance athletes, the variable for gastrointes-
tinal problems was veriﬁed by lower current EA. Persistent
energy deﬁciency causes mucosal atrophy characterised by
diminished intestinal function as well as morphological
changes,29 linking lower current EA to gastrointestinal
problems.
Table 1 Variables associated with lower current energy
availability, menstrual dysfunction and impaired bone health
Variable Verifying variable OR 95% CI
Gastrointestinal symptoms Lower current EA 3.39 1.03 to 11.15*
Injuries Low BMD 1.43 1.04 to 1.96*
Menstrual dysfunction Menstrual dysfunction 1.65 1.23 to 2.20**
OR >1 is a risk factor and indicates the contribution of the different LEAF-Q variables
to lower current energy availability, menstrual dysfunction and low-BMD, respectively.
*p<0.05, **p<0.01.
BMD, bone mineral density; EA, energy availability; LEAF-Q, Low Energy Availability
in Females Questionnaire.
Table 2 Correlations between total LEAF-Q and variable scores
Total LEAF scale score Rho
Gastrointestinal symptoms 0.53**
Injuries 0.49**
Menstrual dysfunction 0.87**
Pearson’s correlation coefficient, **p<0.01.
LEAF-Q, Low Energy Availability in Females Questionnaire.
Table 3 Cronbach’s α for variables, and total LEAF-Q test scale
Item α
Gastrointestinal symptoms 0.75
Injuries 0.79
Menstrual dysfunction 0.61
Test scale 0.71
LEAF-Q, Low Energy Availability in Females Questionnaire.
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Thein-Nissenbaum et al30 showed an increased risk for mus-
cular skeletal injuries in female athletes with restricted eating
behaviour and MD. These results conﬁrm earlier ﬁndings of
increased risk for muscular skeletal injuries in female athletes
with restricted eating behaviour, MD as well as low BMD.11 In
this group of female endurance athletes, the LEAF injury score
correlated with impaired bone health and not with MD or
current EA. A subanalysis showed that the group with impaired
bone health exercised more compared with those with normal
BMD (13.4±5.1 h/week vs 9.6±2.5 h per week, p<0.01), sup-
porting similar ﬁndings regarding impaired bone health in
studies with female elite athletes from weight-bearing endurance
sports.26 31 Furthermore, it is well established that prolonged,
exhaustive endurance exercise is capable of inducing skeletal
muscle damage and temporary impairment of muscle func-
tion,32 making the association between LEAF injury score and
impaired bone health physiological plausible.
PCOS is reported as common among female elite athletes,13
and is not associated with hypothalamic inhibition because of
energy deﬁciency. In this group of athletes, however, three of
ﬁve participants diagnosed with PCOS or a MD other than oli-
gomenorrhoea/FHA had low BMD and four had lower current
EA. Our ﬁndings emphasise the importance of differential diag-
noses in order to secure proper intervention for MD in female
athletes and indicate that assessment of coexisting Triad condi-
tions could be relevant despite the type of MD.
Efforts were made to improve content validity through focus-
ing on physiological plausibility, examining the research litera-
ture to identify the most discriminating variables between the
participants with long-term energy deﬁciency. The strength of
this study is that standardised objective methods have been used
to assess DE/ED, orthostatic BP and reproductive function as
well as bone health. Gastrointestinal function, including stool
frequency and consistency, as well as reproductive function and
the reason for use of OC, are personal issues, and questions in
this regard may be considered offensive and as intimidating with
regard to personal integrity. Therefore, the LEAF-Q and the
results should be carefully administered and evaluated by medic-
ally qualiﬁed personal. The LEAF-Q has thus far been validated
only in this group of female endurance athletes. Since sports-
speciﬁc issues may be relevant to assess, the LEAF-Q needs to
Table 5 Prevalence of triad-associated conditions in all
participants and divided by total LEAF-Q score
All LEAF-Q ≥8 LEAF-Q <8
(N=45) (n=28) (n=17)
BMD Z-score ≤−1¤ (N=17) (n=13) (n=4)
BMD Z-score ≤−2¤ (N=4) (n=2) (n=2)
Eating disorders (N=11) (n=7) (n=4)
Disordered eating (N=1) (n=1) (n=0)
Underweight (BMI <18.5) (N=6) (n=5) (n=1)
Menstrual dysfunction (N=29) (n=23) (n=6)**
Hypotension (N=7) (n=6) (n=1)
Hypoglycaemia (N=16) (n=13) (n=3)*
*p<0.05, **p<0.01, tested with Fisher’s exact test.
BMD, bone mineral density; BMI, body mass index, ¤ determined by DEXA scan;
DEXA, LEAF-Q, Low Energy Availability in Females Questionnaire.
Table 4 Descriptive details on all participants and divided by total LEAF-Q score
All (n=45) LEAF-Q ≥8 (n=28) LEAF-Q <8 (n=17) p Value
Age (years) 26.6±5.4 26.0±5.6 27.5±5.1 0.35
Height (cm) 169.3±0.05 168.7±0.06 170.2±0.05 0.38
Weight (kg) 58.7±6.8 57.1±6.4 61.2±7.0 0.05
BMI (kg/m2) 20.5±1.8 20.0±1.7 21.1±1.9 0.06
Body fat (%) 20.2±3.4 19.2±3.2 21.8±3.4 0.01
Whole body Z-score 0.1 (−0.7–0.4) −0.1 (−0.7–0.5) 0.2 (−0.7–0.4) 0.91
Lumbar spine Z-score −0.7 (−1.6 to −0.1) −0.8 (−1.6 to −0.2) −0.7 (−1.3–0.3) 0.39
EA (kJ/kg FFM/day) 161±58 156±55 169±64 0.49
Energy balance (%) 86±19 85±18 89±21 0.46
EDI-3
DT-score 4.0 (1.0–9.0) 4.0 (1.5–9.0) 4.0 (0.0–9.5) 0.16
BD-score 5.5 (2.0–10.5) 5.0 (3.0–10.0) 6.0 (2.0–17.0) 0.29
Blood pressure (mm Hg)
Supine systolic 113.0±10.6 111.5±11.1 115.4±9.7 0.24
Supine diastolic 68.2±9.5 66.1±8.4 71.4±10.5 0.07
Standing systolic 111.7±10.5 109.2±9.9 115.4±10.5 0.06
Standing diastolic 72.3±9.1 70.4±8.9 75.1±9.0 0.10
T3 (ng/mL) 1.61±0.27 1.54±0.22 1.74±0.29 0.01
Cortisol (nmol/L) 453±135 477±142 412±115 0.13
Leptin (pg/mL) 2.9 [1.6–4.1] 2.0 [1.4–3.2] 4.1 [1.4–5.3] <0.01
(pg/mL/kg FM) 0.24±0.17 0.21±0.19 0.29±0.31 0.02
Glucose (mmol/L) 4.1±0.5 4.0±0.5 4.3±0.3 0.02
Exercise (h/week) 11.3±4.3 11.7±4.8 10.6±3.2 0.39
VO2peak (l/min) 3.2±0.4 3.2±0.4 3.2±0.4 0.78
VO2peak (mL/kg/min) 55.7 [48.2–58.8] 56.7 [49.2–61.2] 52.4 [46.5–56.0] 0.13
Data are presented as mean±SD for normal distributed data and as median and IQR (25–75) for skewed data. Student’s paired t test was used after skewed data were log transformed.
BD-score, body dissatisfaction score; BMI, body mass index (kg/m2); DT-score, drive for thinness score; EA, energy availability, EDI-3, Eating Disorder Inventory-3; FM, fat mass; LEAF-Q,
Low Energy Availability in Females Questionnaire; T3: triiodothyronine; VO2peak: maximal oxygen uptake, ¤ determined by DEXA scan.
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be tested in other areas, such as aesthetic sports and sports that
require weight categories for competition, and also in sports not
focusing on weight, such as soccer and team handball.
The LEAF-Q is brief and could be considered for use to iden-
tify female athletes at risk of the Triad in order to promote early
detection and treatment.
What are the new ﬁndings?
▸ Validated screening tool.
▸ Identiﬁed female athletes at risk for the Triad.
How might it impact on clinical practice?
Could enable early detection and intervention.
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